| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| g | ¥ ƭƭŒħħ | > 0 | > 0 | ¥ ƭƭŒħħ | - + | ||||
| 5g | ¥ æħŒħħ | > 0 | > 0 | 4 | ¥ æħŒħħ | - + | |||
| 0g | ¥ ƈƈŝŒħħ | > 0 | 6 | -- | ¥ ƈƈŝŒħħ | - + | |||
| 25g | ¥ ČǡƈŒħħ | > 0 | 2 | ¥ ČǡƈŒħħ | - + | ||||
| 00g | ¥ ŝƭƭŒħħ | 5 | -- | -- | -- | -- | -- | ¥ ŝƭƭŒħħ | - + |
| 500g | ¥ ƀƈƈƀŒħħ | -- | -- | -- | -- | -- | ¥ ƀƈƈƀŒħħ | - + | |
| 000g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
28.6
[]. Harvey Wong, et al. 6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamineA receptor occupancy in rats. Drug Metab Dispos. 2007 Aug;5(8):87-92.
[2]. La?la El Kihel, et al. New lithocholic and chenodeoxycholic piperazinylcarboxamides with antiproliferative and pro-apoptotic effects on human cancer cell lines. Bioorg Med Chem. 2008 Sep 5;6(8):877-44.
[]. P Giral, et al. Pharmacological evidence for the involvement of -(2-pyridinyl)-piperazine (-PmP) in the interaction of buspirone or gepirone with noradrenergic systems. Eur J Pharmacol. 987 Jan 28;4():-6.
H5-H9-H5
P26-P264-P27-P280-P02+P52-P04+P40-P62-P405-P50
![]()
![]()